Fresenius Medical Care Valuation Multiples

Fresenius Medical Care Overview

About Fresenius Medical Care

Fresenius Medical Care is the largest dialysis company in the world, treating about 300,000 patients from nearly 3,700 clinics worldwide as of December 2024. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.

Founded

1996

HQ

Employees

109.7K

Website

freseniusmedicalcare.com

Sectors

Medical DevicesMedical SuppliesHealthTech

Financials (LTM)

Revenue: $23B

EBITDA: $4B

EV

$23B

Valuation Multiples

Multiples.vc

Start free trial

Fresenius Medical Care Financials

Fresenius Medical Care reported last 12-month revenue of $23B and EBITDA of $4B.

In the same LTM period, Fresenius Medical Care generated $6B in gross profit, $4B in EBITDA, and $1B in net income.

Fresenius Medical Care P&L

In the most recent fiscal year, Fresenius Medical Care reported revenue of $23B and EBITDA of $4B.

Fresenius Medical Care expects next 12-month revenue of XXX and NTM EBITDA of XXX

Fresenius Medical Care Stock Performance

Fresenius Medical Care has current market cap of $13B, and enterprise value of $23B.

Fresenius Medical Care's stock price is $45.89.

Fresenius Medical Care Valuation Multiples

Fresenius Medical Care trades at 1.0x EV/Revenue multiple, and 5.5x EV/EBITDA.

Fresenius Medical Care Financial Valuation Multiples

As of April 19, 2026, Fresenius Medical Care has market cap of $13B and EV of $23B.

Equity research analysts estimate Fresenius Medical Care's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Fresenius Medical Care has a P/E ratio of 10.8x.

Fresenius Medical Care Margins & Growth Rates

Fresenius Medical Care's revenue in the last 12 month grew by 1%.

Fresenius Medical Care's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.0M for the same period.

Fresenius Medical Care's rule of 40 is 18% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Fresenius Medical Care's rule of X is 17% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Fresenius Medical Care Public Comps

See public comps and valuation multiples for other Medical Devices and Medical Supplies comps.

Fresenius Medical Care M&A Activity

Fresenius Medical Care acquired XXX companies to date.

Last acquisition by Fresenius Medical Care was on XXXXXXXX, XXXXX. Fresenius Medical Care acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

Fresenius Medical Care Investment Activity

Fresenius Medical Care invested in XXX companies to date.

Fresenius Medical Care made its latest investment on XXXXXXXX, XXXXX. Fresenius Medical Care invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).